# Rosuvastatin for Preventing Deep Vein Thrombosis

> **NCT01021488** · PHASE4 · UNKNOWN · sponsor: **Hallym University Medical Center** · enrollment: 180 (estimated)

## Conditions studied

- Deep Vein Thrombosis
- Venous
- Thrombosis
- Prevention

## Interventions

- **DRUG:** Rosuvastatin 20mg/d for 14days
- **DRUG:** enoxaparin only

## Key facts

- **NCT ID:** NCT01021488
- **Lead sponsor:** Hallym University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-10
- **Primary completion:** 2011-12
- **Final completion:** 2012-03
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2011-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01021488

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01021488, "Rosuvastatin for Preventing Deep Vein Thrombosis". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01021488. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*